Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Rafael Reports Phase 3 Trappsol Cyclo Data In NPC

(RTTNews) - Wednesday, Rafael Holdings (RFL) reported topline results from the pivotal Phase 3 TransportNPC study evaluating Trappsol Cyclo in patients with Niemann-Pick Disease Type C (NPC).

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Finance & Markets

More from Wednesday 30 September →